Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Gilenya prescribing information
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Galectin-1 for neuroprotection?
Clinical overview of the seizure risk of dalfampridine.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Pages
« first
‹ previous
…
99
100
101
102
103
104
105
106
107
…
next ›
last »